Denali Therapeutics’ $500 Million Private Placement Financing

Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics Inc. on the transaction.Denali Therapeutics (Nasdaq: DNLI) announced that it entered into a securities purchase agreement with certain…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now